La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

First Sponsor Group Bilan de santé

Santé financière contrôle des critères 2/6

First Sponsor Group possède un total de capitaux propres de SGD2.1B et une dette totale de SGD1.4B, ce qui porte son ratio d'endettement à 67.8%. Son actif total et son passif total sont SGD4.8B et de SGD2.7B. L'EBIT de First Sponsor Group est SGD57.9M ce qui fait que son ratio de couverture des intérêts 1.5. Elle dispose de liquidités et de placements à court terme de SGD208.6M.

Informations clés

67.8%

Ratio d'endettement

S$1.42b

Dette

Ratio de couverture des intérêts	1.5x
Argent liquide	S$208.62m
Fonds propres	S$2.10b
Total du passif	S$2.71b
Total des actifs	S$4.81b

Mises à jour récentes de la santé financière

Here's Why First Sponsor Group (SGX:ADN) Is Weighed Down By Its Debt Load

Oct 03

These 4 Measures Indicate That First Sponsor Group (SGX:ADN) Is Using Debt Extensively

Jun 03

First Sponsor Group (SGX:ADN) Takes On Some Risk With Its Use Of Debt

Jan 24

Recent updates

First Sponsor Group's (SGX:ADN) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 09

Here's Why First Sponsor Group (SGX:ADN) Is Weighed Down By Its Debt Load

Oct 03

These 4 Measures Indicate That First Sponsor Group (SGX:ADN) Is Using Debt Extensively

Jun 03

One First Sponsor Group Limited (SGX:ADN) Analyst Is Reducing Their Forecasts For This Year

Apr 29

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de ADN ( SGD2.2B ) dépassent ses passifs à court terme ( SGD1.5B ).

Passif à long terme: Les actifs à court terme de ADN ( SGD2.2B ) dépassent ses passifs à long terme ( SGD1.2B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de ADN ( 57.9% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de ADN est passé de 52.4% à 67.8% au cours des 5 dernières années.

Couverture de la dette: Le flux de trésorerie opérationnel de ADN est négatif, par conséquent la dette n'est pas bien couverte.

Couverture des intérêts: Les paiements d'intérêts de ADN sur sa dette ne sont pas bien couverts par l'EBIT ( 1.5 x couverture).

First Sponsor Group Bilan de santé

Santé financière contrôle des critères 2/6

Informations clés

Mises à jour récentes de la santé financière

Here's Why First Sponsor Group (SGX:ADN) Is Weighed Down By Its Debt Load

These 4 Measures Indicate That First Sponsor Group (SGX:ADN) Is Using Debt Extensively

First Sponsor Group (SGX:ADN) Takes On Some Risk With Its Use Of Debt

Recent updates

Upcoming dividend of S$0.011 per share

New minor risk - Earnings quality

Final dividend of S$0.011 announced

First Sponsor Group Limited Announces Retirement of Yee Chia Hsing as the Lead Independent Director and Non-Executive Director

First Sponsor Group's (SGX:ADN) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Full year 2023 earnings released: EPS: S$0.013 (vs S$0.14 in FY 2022)

First Sponsor Group Limited, Annual General Meeting, Apr 25, 2024

High number of new directors

First Sponsor Group Limited Appoints Ms. Low Beng Lan as Independent Non-Executive Director

Non-Executive Chairman exercised options to buy S$944k worth of stock.

Full year 2023 earnings released: EPS: S$0.013 (vs S$0.14 in FY 2022)

First Sponsor Group Limited Proposes Final Cash Dividend for the Year Ended December 31, 2023, Payable on 27 May 2024

New minor risk - Financial data availability

Here's Why First Sponsor Group (SGX:ADN) Is Weighed Down By Its Debt Load

New minor risk - Shareholder dilution

Upcoming dividend of S$0.011 per share at 3.1% yield

New major risk - Financial position

First Sponsor Group Limited Declares First Interim Tax-Exempt Dividend for the Financial Year Ending 31 December 2023, Payable on 2 October 2023

Upcoming dividend of S$0.027 per share at 3.0% yield

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Alternate Director recently bought S$132k worth of stock

Full year 2022 earnings: EPS and revenues exceed analyst expectations

First Sponsor Group Limited Proposes Final Dividend for the Financial Year Ended 31 December 2022 Paid on or Around 19 May 2023

Insufficient new directors

Price target decreased to S$1.39

Insufficient new directors

Insufficient new directors

First Sponsor Group Limited Appoints Mr. Frans Van Toor as Chief Executive Officer (European Office & Residential Operations)

First Sponsor Group Limited Announces Change of Singapore Business Office Address

Price target decreased to S$1.39

Insufficient new directors

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

First Sponsor Group Limited, Annual General Meeting, Apr 26, 2022

Insufficient new directors

Upcoming dividend of S$0.024 per share

Consensus forecasts updated

Group CEO & Executive Director exercised options to buy S$4.2m worth of stock.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

First Sponsor Group Limited Announces Second Interim Tax-Exempt (One-Tier) Dividend for the Financial Year Ended 31 December 2021, Payable on or About 1 April 2022

Upcoming dividend of S$0.011 per share

Alternate Director exercised options to buy S$932k worth of stock.

Non-Executive Chairman recently bought S$879k worth of stock

Consensus EPS estimates increase to S$0.11

These 4 Measures Indicate That First Sponsor Group (SGX:ADN) Is Using Debt Extensively

One First Sponsor Group Limited (SGX:ADN) Analyst Is Reducing Their Forecasts For This Year

Full year 2020 earnings released: EPS S$0.12 (vs S$0.22 in FY 2019)

New 90-day high: S$1.39

Non-Executive Chairman recently bought S$274k worth of stock

First Sponsor Group Limited (SGX:ADN) entered into a conditional sale and purchase agreement to acquire Guangzhou Panyu Chuang's Real Estate Development Company Limited from Chuang's China Realty Limited for CNY 1.6 billion.

Full year 2020 earnings released: EPS S$0.12 (vs S$0.22 in FY 2019)

Revenue and earnings miss expectations

Upcoming Dividend of S$0.02 Per Share

New 90-day high: S$1.36

First Sponsor Group (SGX:ADN) Takes On Some Risk With Its Use Of Debt

Update: First Sponsor Group (SGX:ADN) Stock Gained 14% In The Last Five Years

First Sponsor Group (SGX:ADN) Is Growing Earnings But Are They A Good Guide?

Analysts lower revenue estimates to S$255.3m

Third quarter earnings released

New 90-day high - S$1.32

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines